Stephen J Russell, MD, PhD

Professor

  • 21956 Citations
  • 79 h-Index
1986 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Measles virus Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Viruses Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Amyloidosis Medicine & Life Sciences
Vesicular Stomatitis Medicine & Life Sciences
Genetic Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2021

Mengovirus
Oncolytic Virotherapy
Replicon
Oncolytic Viruses
Capsid

NIS PROTEINS WITH ALTERED ANION SPECIFICITY

Russell, S. J. & Lech, P.

National Institutes of Health

9/16/149/15/15

Project: Research projectSmall Business Innovation Research Grants (SBIR) - Phase I

Anions
Iodides
Sodium Pertechnetate Tc 99m
Reporter Genes
Thyroid Gland

Measles Virotherapy for Multiple Myeloma

Dispenzieri, A. & Russell, S. J.

National Institutes of Health

7/18/1212/31/15

Project: Research projectResearch Project

Measles
Multiple Myeloma
Viruses
Antibody Formation
Cyclophosphamide

Virotherapy for Squamous Cell Carcinoma of the Head and Neck

Russell, S. J. & Qiao, J.

National Institutes of Health

9/22/108/31/11

Project: Research projectSmall Business Innovation Research Grants (SBIR) - Phase II

Head and Neck Neoplasms
Squamous Cell Neoplasms
Oncolytic Viruses
Therapeutics
Measles virus

Adipocyte insulin signaling in metabolism and aging

Russell, S. J.

National Institutes of Health

8/15/087/31/13

Project: Research projectClinical Investigator Award (CIA)

Adipocytes
Fats
Insulin
Insulin Receptor
Knockout Mice

Research Output 1986 2018

9 Citations

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

Sidana, S., Tandon, N., Dispenzieri, A., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Kapoor, P., Kyle, R. A., Leung, N., Go, R. S., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Rajkumar, S. V. & 1 othersKumar, S. K., Mar 1 2018, In : Leukemia. 32, 3, p. 729-735 7 p.

Research output: Contribution to journalArticle

Amyloidosis
Light
Serum
Survival
Stem Cell Transplantation
9 Citations

Clinical trials with oncolytic measles virus: Current status and future prospects

Msaouel, P., Opyrchal, M., Dispenzieri, A., Peng, K-W., Federspiel, M. J., Russell, S. J. & Galanis, E., Jan 1 2018, In : Current Cancer Drug Targets. 18, 2, p. 177-187 11 p.

Research output: Contribution to journalReview article

Oncolytic Viruses
Measles virus
Clinical Trials
Breast Neoplasms
Viruses
5 Citations

Comparative oncology evaluation of intravenous recombinant oncolytic vesicular stomatitis virus therapy in spontaneous canine cancer

Naik, S., Galyon, G. D., Jenks, N. J., Steele, M. B., Miller, A. C., Allstadt, S. D., Suksanpaisan, L., Peng, K-W., Federspiel, M. J., Russell, S. J. & LeBlanc, A. K., Jan 1 2018, In : Molecular Cancer Therapeutics. 17, 1, p. 316-326 11 p.

Research output: Contribution to journalArticle

Vesicular Stomatitis
Canidae
Viruses
Dogs
Neoplasms

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

Muchtar, E., Dispenzieri, A., Leung, N., Lacy, M., Buadi, F. K., Dingli, D. M., Grogan, M., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Chakraborty, R., Gonsalves, W., Kourelis, T. V., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 5 othersZeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Gertz, M., Feb 20 2018, (Accepted/In press) In : Leukemia. p. 1-10 10 p.

Research output: Contribution to journalArticle

Tissue Survival
Amyloidosis
Kidney
Cell- and Tissue-Based Therapy
Plasma Cells
1 Citations

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

Lakshman, A., Singh, P. P., Rajkumar, S. V., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F. K., Dingli, D. M., Hwa, Y. L., Fonder, A. L., Hobbs, M., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Lin, Y., Gonsalves, W. & 4 othersKourelis, T., Warsame, R., Kyle, R. A. & Kumar, S. K., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Stem Cells
Transplants
Survival